SHSE:688739'
s EV-to-FCF Range Over the Past 10 Years
Min: -12506.41 Med: 62.84 Max: 851.27
Current: 73.07
During the past 13 years, the highest EV-to-FCF of Liaoning Chengda Biotechnology Co was 851.27. The lowest was -12506.41. And the median was 62.84.
SHSE:688739's EV-to-FCF is ranked worse than 83.89% of 329
companies
in the Biotechnology industry
Industry Median: 16.38
vs SHSE:688739: 73.07
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Liaoning Chengda Biotechnology Co (SHSE:688739) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Liaoning Chengda Biotechnology Co's PE Ratio (TTM) for today is calculated as:
Liaoning Chengda Biotechnology Co's share price for today is ¥19.65.
Liaoning Chengda Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.140.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Liaoning Chengda Biotechnology Co EV-to-FCF Related Terms
Liaoning Chengda Biotechnology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688739 vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Liaoning Chengda Biotechnology Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Liaoning Chengda Biotechnology Co's EV-to-FCF falls into.
Liaoning Chengda Biotechnology Co's current Enterprise Value is ¥3,385 Mil.
Liaoning Chengda Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥42 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liaoning Chengda Biotechnology Co (SHSE:688739) has a EV-to-FCF of 79.74 as of Jul. 07, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Liaoning Chengda Biotechnology Co and its competitors. This is 27% above median its historical median of 62.84. According to the industry distribution chart, Liaoning Chengda Biotechnology Co ranks #276 out of 329 companies in the Biotechnology industry, placing it in the top 83.9%.
Is Liaoning Chengda Biotechnology Co's EV-to-FCF too high?
Liaoning Chengda Biotechnology Co's current EV-to-FCF of 79.74 is 27% above median its 10-year median of 62.84. The Biotechnology industry median EV-to-FCF is 16.38. Liaoning Chengda Biotechnology Co's value of 79.74 is 386.8% above this industry median. Based on the distribution chart, Liaoning Chengda Biotechnology Co ranks #276 out of 329 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Liaoning Chengda Biotechnology Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Liaoning Chengda Biotechnology Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Liaoning Chengda Biotechnology Co ranks #276 out of 329 companies for EV-to-FCF. This places Liaoning Chengda Biotechnology Co in the lower half of its industry. The industry median EV-to-FCF is 16.38. Liaoning Chengda Biotechnology Co's value of 79.74 is 386.8% above this benchmark. While the company's 10-year median is 62.84 vs. the industry median of 16.38, Liaoning Chengda Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 16.38, based on 329 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Liaoning Chengda Biotechnology Co's current EV-to-FCF of 79.74 is 386.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Liaoning Chengda Biotechnology Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 16.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Liaoning Chengda Biotechnology Co's current EV-to-FCF is 79.74, which is 27% above median its own 10-year median of 62.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liaoning Chengda Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co (SHSE:688739) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.14, compared to a current price of ¥19.65 — trading 11.2% below its estimated fair value. The current EV-to-FCF is 79.74, which is 27% above median its 10-year median of 62.84 and 386.8% above the Biotechnology industry median of 16.38. Liaoning Chengda Biotechnology Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Liaoning Chengda Biotechnology Co (SHSE:688739), the current EV-to-FCF is 79.74 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Liaoning Chengda Biotechnology Co (SHSE:688739) Overvalued in 2026?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co stock appears to be undervalued.
The current stock price of ¥19.65 is trading 11.2% below its estimated GF Value™ of ¥22.14.
GuruFocus considers Liaoning Chengda Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688739:
EV-to-FCF: 79.74 (27% above median its 10-year median of 62.84)
GF Value™: ¥22.14 vs. price of ¥19.65 (11.2% below fair value)
Industry Position: 386.8% above the Biotechnology median (#276 of 329)
No single metric tells the full story. See the SHSE:688739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Liaoning Chengda Biotechnology Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688739 has been successfully added to your 
